Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2020 | Regulation helps deliver CAR T-cell therapy efficiently

Here, Ulrich Jäger, MD, Medical University of Vienna, Vienna, Austria, outlines the importance of regulation when a novel therapy such as CAR T-cell therapy is introduced, and what to expect from the regulatory session taking place on Day 2 of the 2nd European CAR T-cell Meeting in Sitges, Spain.

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.